MGMT promoter methylation in plasma of glioma patients receiving temozolomide.
Autori:
Fiano V, Trevisan M, Trevisan E, Senetta R, Castiglione A, Sacerdote C, Gillio-Tos A, De Marco L, Grasso C, Magistrello M, Tondat F, Rudà R, Cassoni P, Soffietti R, Merletti F.
Rivista:
J Neurooncol 2014; 117: 347-57. (IF 2.787)